NYSEMKT: CATXPerspective Therapeutics Inc Stock Ownership - Who owns Perspective Therapeutics?
Insider buying vs selling
Have Perspective Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Robert F. Williamson Iii | Director | 2025-03-31 | 38,145 | $2.14 | $81.78kBuy |
| Lori A. Woods | Director | 2025-03-31 | 23,475 | $2.13 | $50.00kBuy |
| Juan Graham | Chief Financial Officer | 2025-03-28 | 33,333 | $2.25 | $74.93kBuy |
| Johan M. Spoor | Chief Executive Officer | 2025-03-28 | 22,026 | $2.24 | $49.38kBuy |
| Johan M. Spoor | Chief Executive Officer | 2025-03-28 | 4,650 | $2.21 | $10.29kBuy |
| Robert F. Williamson Iii | Director | 2025-03-28 | 22,192 | $2.27 | $50.38kBuy |
| Johan M. Spoor | CEO | 2024-12-04 | 8,000 | $3.77 | $30.14kBuy |
| Heidi Henson | Director | 2024-12-04 | 25,975 | $3.85 | $100.00kBuy |
| Johan M. Spoor | CEO | 2024-11-25 | 14,500 | $3.78 | $54.87kBuy |
| Jonathan Robert Hunt | Chief Financial Officer | 2024-11-25 | 10,000 | $3.88 | $38.80kBuy |
CATX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CATX insiders and whales buy or sell their stock.
CATX Shareholders
What type of owners hold Perspective Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lantheus Alpha Therapy LLC | 157.32% | 116,773,394 | $479.94M | Insider |
| Fmr LLC | 13.54% | 10,050,739 | $41.31M | Institution |
| Blackrock Inc | 5.35% | 3,971,525 | $16.32M | Institution |
| Vanguard Group Inc | 4.13% | 3,067,051 | $12.61M | Institution |
| Deerfield Management Company LP Series C | 3.81% | 2,829,413 | $11.63M | Institution |
| Octagon Capital Advisors LP | 3.03% | 2,250,000 | $9.25M | Institution |
| Affinity Asset Advisors LLC | 3.00% | 2,224,196 | $9.14M | Institution |
| Avidity Partners Management LP | 2.96% | 2,197,270 | $9.03M | Institution |
| Nicholson Wealth Management Group LLC | 2.17% | 1,609,283 | $6.61M | Institution |
| Morgan Stanley | 2.10% | 1,558,451 | $6.41M | Institution |
CATX vs Medical Device Stocks
Perspective Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.